Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.733
+0.101 (15.95%)
At close: Mar 9, 2026, 4:00 PM EDT
0.710
-0.023 (-3.10%)
After-hours: Mar 9, 2026, 7:55 PM EDT
Werewolf Therapeutics Revenue
In the year 2024, Werewolf Therapeutics had annual revenue of $1.89M, down -90.55%.
Revenue (ttm)
$1.89M
Revenue Growth
-90.55%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
35.57M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHOWL News
- 13 days ago - Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - GlobeNewsWire
- 2 months ago - Werewolf Therapeutics Announces Pipeline and Business Updates - GlobeNewsWire
- 4 months ago - Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire
- 4 months ago - Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer - GlobeNewsWire
- 5 months ago - Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire
- 6 months ago - Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire